Texas Liver Institute is a clinical research site located in Austin, Texas, United States 78757.
Crixeo Health Trust Score: 63/100 (FAIR). This profile has not yet been claimed by the site owner.
Texas Liver Institute has participated in 3 clinical trials.
Therapeutic areas: Non-alcoholic Steatohepatitis (NASH), Moderate to Extensive Hepatic Fibrosis (METAVIR F3-4), Hepatic Impairment.
Sponsors: Boehringer Ingelheim, Bristol-Myers Squibb, Mirati Therapeutics Inc..
Trust Score: 63/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Texas Liver Institute has a Crixeo Trust Score of 63/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Texas Liver Institute has 3 clinical trials on record. Their work covers Non-alcoholic Steatohepatitis (NASH), Moderate to Extensive Hepatic Fibrosis (METAVIR F3-4), Hepatic Impairment.
Texas Liver Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.